Neoadjuvant Aumolertinib for unresectable stage III EGFR-mutant non-small cell lung cancer: a single-arm phase II trial

Dongliang Bian(Tongji University), Peng Zhang(Tongji University), Wenxin He(Tongji University), Gening Jiang(Tongji University), Deping Zhao(Second Military Medical University), Xinsheng Zhu(Tongji University), Liang Duan(Dalian Medical University), Lei Jiang(Affiliated Hospital of Qingdao University), Jie Huang(Shanghai Pulmonary Hospital), Yirui Zhou(Tongji University), Xiaogang Liu(Tongji University), Jing Liu(Tongji University), Dong Xie(Jiangsu University), Lele Zhang(Tongji University), Liangdong Sun(Tongji University), Zhida Huang(Fujian Medical University), Jie Yang(Tongji University), Jing Zhang(University of South Dakota), Yue Liu(Ningxia Medical University), Chunyan Wu(Shanghai Pulmonary Hospital), Junjie Hu(Tongji University), Xiao Bao(People's Hospital of Yangzhong), Yuming Zhu(Chinese Academy of Medical Sciences & Peking Union Medical College), Ming Liu(Tongji University), Shuyu Ji(Tongji University)
Nature Communications
April 2, 2025
Cited by 11


Related Papers